Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TSXV/NGMD stock hub

TSXV/NGMD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/NGMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.7M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/NGMD

In the news

Latest news · TSXV/NGMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC-33.4

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/NGMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

CAD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 19.9M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Medical Devices
Isin	CA67054F1009
Last refreshed	2026-05-10
Market cap	CAD 5.7M
Price	CAD 0.03
Price currency	CAD
Sector	Healthcare
Sic	3841
Symbol	tsxv/NGMD
Website	https://www.nugenmd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-137.88%
EV Earnings	-2.54x
EV/FCF	-5.15x
EV/Sales	77.21x
FCF yield	-68.15%
P/B ratio	-0.41x
P/S ratio	22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	51.31%
Gross Profit	CAD 132,353
Gross Profit Growth	-74.64%
Gross Profit Growth Q	-85.19%
Gross Profit Growth3 Y	10.1%
Gross Profit Growth5 Y	30.94%
Net Income	CAD -7.8M
Pretax Margin	-3,013.85%
ROA	-30.7
Roa5y	-41.05
ROCE	-637.3
ROIC	-33.44

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-54.57%
Cagr3y	-49.99%
Revenue Growth	-74.46x
Revenue Growth Q	-79.73x
Revenue Growth3 Y	19.19x
Revenue Growth5 Y	40.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.03
Assets	CAD 4.3M
Cash	CAD 3.1M
Current Assets	CAD 4M
Current Liabilities	CAD 3.6M
Debt	CAD 17.4M
Debt FCF	CAD -4.49
Equity	CAD -13.7M
Liabilities	CAD 18M
Long Term Assets	CAD 299,179
Long Term Liabilities	CAD 14.4M
Net Cash	CAD -14.2M
Net Cash By Market Cap	CAD -251
Tangible Book Value	CAD -13.7M
Tangible Book Value Per Share	CAD -0.06
WACC	3.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.1
Inventory Turnover	0.31
Net Working Capital	CAD 206,307
Quick ratio	0.9
Working Capital	CAD 363,036

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-54.55%
200-day SMA	0.04
3Y total return	-87.5%
50-day SMA	0.03
50-day SMA vs 200-day SMA	50under200
All Time High	0.53
All Time High Change	-95.28%
All Time High Date	2021-11-10
All Time Low	0.02
All Time Low Change	66.67%
All Time Low Date	2026-04-08
ATR	0
Beta	1.56
Beta1y	-0.3
Beta2y	-0.13
Ch YTD	-16.67
High	0.03
High52	0.08
High52 Date	2025-05-23
High52ch	-68.75%
Low	0.03
Low52	0.02
Low52 Date	2026-04-16
Low52ch	66.67%
Ma50ch	-7.41%
Price vs 200-day SMA	-42.4%
RSI	50
RSI Monthly	33.46
RSI Weekly	36.98
Sharpe ratio	0.13x
Sortino ratio	0.26
Total Return	-5.82%
Tr YTD	-16.67
Tr1m	25%
Tr3m	-16.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -4.2M
Operating margin	-1,636.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	221,599,968%
Shares Insiders	2.39%
Shares Out	227,035,682
Shares Qo Q	0%
Shares Yo Y	5.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -3.9M
Average Volume	373,193.15x
Bv Per Share	-0.06
CAPEX	CAD -302,313
Ch1m	25
Ch1y	-54.55
Ch3m	-16.67
Ch3y	-87.5
Ch6m	-37.5
Change	25%
Change From Open	0
Close	0.02
Days Gap	25
Depreciation Amortization	691,071
Dollar Volume	5,000
Earnings Date	2026-05-14
EBIT	CAD -4.2M
EBITDA	CAD -3.5M
EPS	CAD -0.04
F Score	2
FCF	CAD -3.9M
FCF EV Yield	-19.42x
FCF Per Share	CAD -0.02
Financing CF	60,500
Fiscal Year End	December
Income Tax	CAD 51,969
Investing CF	-303,754
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2025-12-31
Last Split Date	2021-11-08
Last Split Type	Reverse
Ma150	0.04
Ma150ch	-34.38%
Ma20	0.02
Ma20ch	6.38%
Net CF	-3,809,107
Next Earnings Date	2026-05-14
Open	0.03
Ppne	299,179
Price Date	2026-05-08
Relative Volume	0.54x
Revenue	257,949x
Tax By Revenue	20.15x
Tr6m	-37.5%
Volume	200,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/NGMD pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/NGMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/NGMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.8%

Negative means the company is buying back shares.

Technical

TSXV/NGMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.0

Neutral momentum band

Price vs 200-day MA

-42.4%

50/200-day relationship not available

Beta (5Y)

1.56

More volatile than the market

Sharpe ratio

0.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/NGMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/NGMD stock rating?

tsxv/NGMD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/NGMD analysis?

The full report lives at /stocks/tsxv/NGMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/NGMD?

The latest report frames tsxv/NGMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/NGMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.